Effects of Glycopyrrolate on Lung Function in COPD
Glycopyrrolate inhalation powder (a long-acting muscarinic antagonist) is administered at 15.6 µg twice daily for the long-term maintenance treatment of airflow obstruction in patients with COPD. Studies indicate that inhalation of the powder may improve lung function significantly in patients with moderate to severe chronic obstructive pulmonary disease (COPD) regardless of baseline smoking status.[i] COPD…